USE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY: CLINICAL EVIDENCE AND NUTRITIONAL IMPLICATIONS. REMUNOM, [S. l.], v. 21, n. 05, p. 1–11, 2025. DOI: 10.61164/dgpn4685. Disponível em: https://remunom.ojsbr.com/multidisciplinar/article/view/5181. Acesso em: 12 apr. 2026.